# 胃肠道支架市场 > 胃肠支架市场研究报告按支架类型（金属支架、塑料支架、自扩张支架、覆盖支架）、按应用（食管支架、胃支架、十二指肠支架、结直肠支架）、按材料（镍钛合金、不锈钢、聚氨酯、硅胶）、按长度（10厘米、10-20厘米、20-30厘米、>30厘米）、按直径（10毫米、10-15毫米、15-20毫米、>20毫米）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.17% - **2024:** $ 3.65 Billion - **2025:** $ 3.84 Billion - **2035:** $ 6.36 Billion - **Key Players:** Boston Scientific (US), Medtronic(US), Cook Medical (US), B. Braun Melsungen AG (DE), ConMed Corporation (US), Olympus Corporation (JP), Hobbs Medical (US), Stryker Corporation (US), Terumo Corporation (JP) **Report ID:** MRFR/HC/27792-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/gastrointestinal-stent-market-29514 --- ## Market Summary ## **Gastrointestinal Stent Market Overview** As per MRFR analysis, the Gastrointestinal Stent Market Size was estimated at 3.65 (USD Billion) in 2024. The Gastrointestinal Stent Market Industry is expected to grow from 3.84 (USD Billion) in 2025 to 6.05 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.17% during the forecast period (2025 - 2034). ### **Key Gastrointestinal Stent Market Trends Highlighted** The Gastrointestinal Stent Market is witnessing a surge in demand, driven by the rising prevalence of gastrointestinal diseases such as esophageal cancer, pancreatic cancer, and colorectal cancer. Technological advancements have led to innovative stent designs, including self-expanding and biodegradable stents, which enhance patient outcomes and reduce complications. The growing adoption of minimally invasive procedures and the increasing awareness of endoscopic stent placement further contribute to market growth. To capture market opportunities, industry players are focusing on expanding their product portfolios with differentiated stent offerings. Collaborations and partnerships with healthcare providers and research institutions are crucial for developing tailored solutions that address specific patient needs. Additionally, advancements in materials science and manufacturing techniques are paving the way for the development of stents with improved biocompatibility and reduced restenosis rates. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Gastrointestinal Stent Market Drivers** Growing Prevalence of Gastrointestinal Diseases Gastrointestinal (GI) diseases are a major global health concern, affecting millions of people worldwide. These diseases include a wide range of conditions, such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and colorectal cancer. The rising prevalence of GI diseases is primarily due to factors such as unhealthy diet, obesity, smoking, and alcohol consumption. As the population ages, the incidence of GI diseases is also expected to increase, as older adults are more susceptible to these conditions. The growing burden of GI diseases is driving the demand for effective treatment options, including gastrointestinal stents. Technological Advancements in Stent Design Technological advancements are continually improving the design and performance of gastrointestinal stents. New stent designs offer enhanced features, such as improved biocompatibility, reduced tissue trauma, and increased flexibility. These advancements are driven by research and development efforts by medical device companies, as well as collaborations with clinicians. The development of innovative stent technologies is expected to contribute to the growth of the Gastrointestinal Stent Market in the coming years. Increasing Awareness and Acceptance of Stent Procedures The growing awareness and acceptance of stent procedures among healthcare professionals and patients is another key driver of the Gastrointestinal Stent Market. Stents are increasingly recognized as a safe and effective treatment option for a variety of GI conditions. Educational campaigns and training programs are helping to raise awareness about the benefits of stent procedures, leading to increased adoption of these treatments. ## **Gastrointestinal Stent Market Segment Insights** ### **Gastrointestinal Stent Market Stent Type Insights** The Gastrointestinal Stent Market segmentation based on Stent Type includes Metallic Stents, Plastic Stents, Self-Expandable Stents, and Covered Stents. Among these, Metallic Stents held the largest market share in 2023. The increasing prevalence of cancer and gastrointestinal disorders is driving demand for Metallic Stents. According to the American Cancer Society, approximately 1.9 million new cases of cancer were diagnosed in the United States alone in 2023. The rising geriatric population, growing incidence of gastrointestinal diseases, and technological advancements are propelling the market growth. Furthermore, the increasing adoption of minimally invasive procedures and the expanding healthcare infrastructure in developing economies present lucrative opportunities for market players. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Gastrointestinal Stent Market Application Insights** The Gastrointestinal Stent Market is segmented by application into [esophageal stents](../../../reports/esophageal-stents-market-27185), gastric stents, duodenal stents, and colorectal stents. Among these, esophageal stents held the largest market share in 2023, accounting for over 30% of the global market revenue. This dominance can be attributed to the high prevalence of esophageal cancer and gastroesophageal reflux disease (GERD), which require stenting procedures to alleviate symptoms and improve patient outcomes. Gastric stents are also witnessing significant growth due to the increasing incidence of gastric cancer and the need for minimally invasive treatment options. The market for duodenal and colorectal stents is expected to grow steadily over the forecast period, driven by the rising prevalence of colorectal cancer and the development of innovative stent designs tailored to specific anatomical challenges. ### **Gastrointestinal Stent Market Material Insights** The Gastrointestinal Stent Market is anticipated to reach significant growth over the forecast period, owing to the increasing prevalence of gastrointestinal disorders and the rising demand for minimally invasive procedures. Among the various materials used in gastrointestinal stents, Nitinol holds the largest market share due to its unique properties, such as shape memory and biocompatibility. Nitinol stents offer excellent flexibility and conformability, allowing them to adapt to complex anatomical structures and reduce the risk of migration or kinking. Stainless Steel stents are another commonly used material, offering high tensile strength and durability. However, their limited flexibility may make them less suitable for certain applications. Polyurethane and Silicone stents, on the other hand, provide softness and flexibility, making them ideal for use in sensitive areas such as the esophagus or colon. The choice of material for a gastrointestinal stent depends on factors such as the specific clinical application, anatomical location, and patient's individual needs. ### **Gastrointestinal Stent Market Length Insights** The Gastrointestinal Stent Market is segmented by length into ' 10 cm', '10-20 cm', '20-30 cm', and '> 30 cm'. Among these segments, the '10-20 cm' segment held the largest market share in 2023, accounting for around 38.5% of the global market. This dominance is attributed to the high prevalence of gastrointestinal diseases, such as esophageal cancer and pancreatic cancer, which require stents in this length range. The ' 10 cm' segment is expected to witness the fastest growth during the forecast period, owing to the increasing adoption of shorter stents for treating conditions in the upper gastrointestinal tract. The '20-30 cm' and '> 30 cm' segments are expected to maintain a steady growth rate, driven by the rising demand for stents for treating complex gastrointestinal disorders. ### **Gastrointestinal Stent Market Diameter Insights** Diameter Segment The diameter segment of the Gastrointestinal Stent Market is segmented into ' 10 mm', '10-15 mm', '15-20 mm', and '> 20 mm'. The ' 10 mm' segment held the largest market share in 2023, accounting for around 40% of the Gastrointestinal Stent Market revenue. The '10-15 mm' segment is expected to witness the highest growth rate during the forecast period (2025-2034), owing to the increasing prevalence of gastrointestinal diseases and the rising adoption of minimally invasive procedures. The '> 20 mm' segment is expected to account for a relatively smaller share of the market due to the limited number of applications for stents of this size. Overall, the Diameter segment is expected to contribute significantly to the growth of the Gastrointestinal Stent Market, driven by the increasing demand for stents in the treatment of gastrointestinal disorders and the technological advancements in stent design and materials. ### **Gastrointestinal Stent Market Regional Insights** The regional segmentation of the Gastrointestinal Stent Market offers valuable insights into the market's geographic distribution and growth patterns. North America holds a significant share of the market due to the high prevalence of gastrointestinal diseases, advanced healthcare infrastructure, and favorable reimbursement policies. Europe is another major market driven by the increasing demand for minimally invasive procedures and the presence of leading manufacturers. The APAC region is projected to witness substantial growth in the coming years, attributed to the rising incidence of gastrointestinal disorders, growing healthcare expenditure, and government initiatives to improve healthcare access. South America and MEA also present opportunities for market expansion, with growing economies and improving healthcare infrastructure fueling market growth. These regional insights are crucial for industry players to identify target markets, optimize distribution channels, and tailor their strategies to meet specific regional needs, thereby driving overall market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review  ## **Gastrointestinal Stent Market Key Players and Competitive Insights** Major players in the Gastrointestinal Stent Market are constantly striving to gain a competitive edge by introducing new and innovative products, expanding their product portfolios, and establishing strategic partnerships. Leading Gastrointestinal Stent Market players are focusing on developing advanced technologies that offer improved clinical outcomes and patient satisfaction. The Gastrointestinal Stent Market Competitive Landscape is characterized by a high level of competition, with established players and emerging companies vying for market share. Companies are investing heavily in research and development to stay ahead of the competition and meet the evolving needs of healthcare providers and patients. Market development initiatives include collaborations, acquisitions, and joint ventures to strengthen market position and expand geographical reach. Boston Scientific Corporation is a leading player in the Gastrointestinal Stent Market, renowned for its innovative medical devices and technologies. The company's Gastroenterology division offers a comprehensive portfolio of gastrointestinal stents designed to treat a range of conditions affecting the digestive tract. Boston Scientific is committed to providing advanced solutions that improve patient outcomes and enhance the delivery of healthcare services. The company's focus on innovation and clinical excellence has solidified its position as a key player in the Gastrointestinal Stent Market. Medtronic plc is another prominent player in the Gastrointestinal Stent Market, recognized for its expertise in medical technology and solutions. The company's Gastrointestinal division offers a wide range of stents and accessories for the treatment of gastrointestinal diseases. Medtronic is dedicated to developing innovative technologies that address unmet medical needs and improve patient care. The company's focus on research and development, combined with its global presence, has enabled it to establish a strong position in the Gastrointestinal Stent Market. **Key Companies in the Gastrointestinal Stent Market Include** ### Gastrointestinal Stent Market Developments - **Q2 2024: Boston Scientific Announces U.S. FDA Clearance of the AXIOS™ Stent and Electrocautery Enhanced Delivery System for Endoscopic Drainage of the Gallbladder** Boston Scientific received FDA clearance for its AXIOS™ Stent and Electrocautery Enhanced Delivery System, expanding its use for endoscopic drainage of the gallbladder in high-risk surgical patients. - **Q1 2024: Olympus Launches HANAROSTENT® Esophagus TTS in Europe** Olympus announced the European launch of the HANAROSTENT® Esophagus TTS, a new through-the-scope self-expanding metal stent designed for the treatment of esophageal strictures. - **Q2 2024: Cook Medical Receives CE Mark for Evolution® Biliary Controlled-Release Stent** Cook Medical received CE Mark approval for its Evolution® Biliary Controlled-Release Stent, allowing expanded commercial distribution in the European Union. - **Q2 2024: Medtronic Announces Partnership with Intuitive Surgical to Advance Endoluminal Stenting Solutions** Medtronic entered a strategic partnership with Intuitive Surgical to co-develop next-generation endoluminal stenting solutions for gastrointestinal procedures. - **Q1 2024: Taewoong Medical Receives U.S. FDA 510(k) Clearance for Niti-S™ Duodenal Stent** Taewoong Medical received 510(k) clearance from the U.S. FDA for its Niti-S™ Duodenal Stent, enabling commercial launch in the United States. - **Q3 2024: Boston Scientific Completes Acquisition of GI Supply** Boston Scientific completed the acquisition of GI Supply, a company specializing in endoscopic devices including gastrointestinal stents, to expand its interventional portfolio. - **Q2 2024: Micro-Tech Endoscopy Launches New Biliary Stent System in the U.S.** Micro-Tech Endoscopy announced the U.S. launch of its new biliary stent system, designed to improve ease of placement and patient outcomes in biliary obstruction cases. - **Q1 2025: Olympus Opens New Manufacturing Facility for Gastrointestinal Stents in Vietnam** Olympus opened a new manufacturing facility in Vietnam dedicated to the production of gastrointestinal stents, aiming to increase global supply capacity. - **Q2 2025: Boston Scientific Receives FDA Approval for Next-Generation WallFlex™ Colonic Stent** Boston Scientific received FDA approval for its next-generation WallFlex™ Colonic Stent, designed for the management of malignant colonic obstructions. - **Q1 2024: Medtronic Appoints New President of Gastrointestinal Business Unit** Medtronic announced the appointment of a new president to lead its Gastrointestinal Business Unit, reflecting a strategic focus on expanding its GI stent portfolio. - **Q3 2024: Taewoong Medical Signs Distribution Agreement with Cardinal Health for U.S. GI Stent Market** Taewoong Medical signed a distribution agreement with Cardinal Health to expand the reach of its gastrointestinal stent products in the United States. - **Q2 2025: Cook Medical Launches New Biodegradable Esophageal Stent in Europe** Cook Medical launched a new biodegradable esophageal stent in Europe, offering an alternative to traditional metal stents for benign esophageal strictures. ## **Gastrointestinal Stent Market Segmentation Insights** ### **Gastrointestinal Stent Market Stent Type Outlook** ### **Gastrointestinal Stent Market Application Outlook** ### **Gastrointestinal Stent Market Material Outlook** ### **Gastrointestinal Stent Market Length Outlook** ### **Gastrointestinal Stent Market Diameter Outlook** ### **Gastrointestinal Stent Market Regional Outlook** ## Market Drivers ### 向微创手术转变 在胃肠支架市场中，向微创手术的明显转变是由患者对较少创伤性治疗选择的偏好所驱动的。微创技术提供了许多优势，包括缩短恢复时间、降低并发症风险和缩短住院时间。随着医疗系统越来越重视以患者为中心的护理，符合这些原则的支架手术的需求正在上升。这一趋势得到了内窥镜技术和工具的进步的支持，这些进步使得支架的放置更加精确。因此，随着越来越多的医疗提供者采用这些创新的治疗方法，胃肠支架市场可能会扩展。 ### 监管支持和报销政策 监管支持和有利的报销政策在塑造胃肠支架市场中至关重要。各国政府和卫生当局越来越认识到胃肠支架作为一种可行治疗选择的重要性，这导致了新支架技术的审批流程更加简化。此外，有利的报销框架鼓励医疗服务提供者更广泛地采用这些干预措施。随着报销政策的发展，覆盖更广泛的支架程序，市场的采用率可能会增加。这种支持性的监管环境预计将促进胃肠支架市场的创新和竞争，最终使患者和医疗系统受益。 ### 胃肠疾病发病率上升 胃肠道疾病的日益普遍，包括结直肠癌、食管狭窄和胆道梗阻，是胃肠道支架市场的重要驱动因素。根据最近的数据，结直肠癌的发病率稳步上升，预计将成为癌症相关死亡的主要原因之一。这一胃肠道疾病的激增需要有效的治疗方案，包括支架置入手术。随着医疗服务提供者寻求应对这些挑战，胃肠道支架的需求预计将上升，进一步推动市场发展。对早期诊断和治疗方案的日益关注可能会增强支架置入手术的采用，从而使胃肠道支架市场受益。 ### 支架设计中的技术进步 胃肠道支架市场正因支架设计和材料的快速技术进步而经历显著转变。生物可降解支架和药物洗脱支架等创新正在获得关注，改善患者的治疗效果并减少并发症。先进成像技术和微创部署方法的引入也在提高手术成功率。因此，预计市场在未来几年将见证约6.5%的年复合增长率。这些进展不仅提高了支架的有效性，还扩展了其在各种胃肠道疾病中的应用，从而推动了胃肠道支架市场的整体增长。 ### 老龄化人口与医疗支出增加 老龄化人口是影响胃肠道支架市场的一个关键因素。随着人们年龄的增长，他们更容易受到各种胃肠道疾病的影响，因此需要进行如支架置入等干预。此外，许多地区医疗支出的增加使得人们能够更好地获得先进的医疗技术，包括胃肠道支架。这一人口结构的变化预计将推动需求，因为老年人通常需要更频繁的医疗关注和干预。老龄化人口与医疗投资上升的结合表明，胃肠道支架市场将呈现出强劲的增长轨迹，因为医疗服务提供者正在适应以满足这一人群的需求。 ## Future Outlook 胃肠支架市场预计将在2024年至2035年间以5.17%的年均增长率增长，推动因素包括技术进步、胃肠疾病的日益普遍以及医疗支出的增加。 **New opportunities:** - 开发可生物降解的支架以增强患者安全性 进入新兴市场，提供量身定制的产品 整合人工智能以实现个性化支架植入解决方案 到2035年，市场预计将实现强劲增长，确立其在胃肠健康解决方案领域的领导地位。 ## Segment Insights ### 按类型：金属支架（最大）与塑料支架（增长最快） 在胃肠道支架市场中，不同类型支架的市场份额分布显示出对金属支架的明显偏好，金属支架因其耐用性和在长期应用中的有效性而主导该细分市场。然而，塑料支架作为一种竞争选择，特别是在特定的临时应用中，逐渐崭露头角，从而占据了显著的市场份额，并显示出良好的增长潜力。胃肠道支架细分市场的增长趋势受到支架材料和设计进步的影响。金属支架继续引领市场，因为它们通常因其强度和抗堵塞能力而受到青睐。相反，塑料支架正在迅速被采用，主要是由于其成本效益和在某些情况下的有效性，使其成为支架细分市场中增长最快的类型。 金属支架（主导）与塑料支架（新兴） 金属支架在胃肠道支架市场中占据主导地位，因其坚固的结构和能够长时间保持通畅的能力。它们在需要长期支持的情况下特别有效，例如恶性梗阻。其表面设计经过优化，以防止组织生长，显著改善患者的治疗效果。另一方面，尽管塑料支架最初被视为临时解决方案，但由于其设计和材料的创新，正在作为一种新兴选择获得关注，这些创新提高了其有效性。它们轻便、易于放置，并为短期应用提供了更低成本的解决方案，吸引了寻求多样化治疗选择的医疗服务提供者。 ### 按应用：食管支架（最大）与胃支架（增长最快） 胃肠道支架市场展现出多样化的应用，目前食管支架在该细分市场中占据主导地位。这主要是由于食管癌及相关疾病的发病率上升，导致对食管支架的需求显著增加。胃支架也在稳步增长，推动因素是胃梗阻的发病率增加以及对微创治疗选择的需求。尽管食管支架保持着相当大的市场份额，但胃支架在该细分市场中代表着最高的增长潜力，这得益于不断变化的患者人口统计和手术进展。在增长趋势方面，胃肠道支架市场正经历向更以患者为中心的微创手术的转变。对早期诊断和胃肠道疾病管理的认识提高，促使先进支架技术的发展，从而推动市场扩展。老年人口的增加，加上慢性胃肠道疾病发病率的上升，推动了对食管和胃支架的需求。此外，持续的临床研究可能为满足未满足的医疗需求的创新产品提供机会，特别是在胃支架应用方面。 食管支架（主导）与胃支架（新兴） 食管支架在胃肠道支架市场中占据主导地位，这归因于它们在治疗恶性吞咽困难和食管狭窄等疾病中的关键作用。这些支架旨在为因肿瘤或狭窄而面临吞咽困难的患者提供持久的解决方案。它们已建立的疗效和安全记录使其成为医疗服务提供者的首选。相比之下，胃支架作为市场的重要组成部分正在崛起，推动其使用的证据不断增加，以缓解胃出口梗阻。设计和材料的创新正在提高胃支架的有效性，以满足不同患者的需求。胃支架作为治疗方式的逐渐采用反映了临床实践的演变，旨在提高患者的舒适度和治疗效果。 ### 按材料：镍钛合金（最大）与不锈钢（增长最快） 胃肠道支架市场展示了多样的材料细分，其中镍钛合金成为支架生产中使用的最大材料。其独特的特性，如柔韧性、形状记忆和生物相容性，使其能够适应各种解剖条件。这种性能的优越性推动了其市场主导地位。不锈钢虽然在历史上具有重要意义，但作为一种增长更快的材料正在经历复苏。制造方法的创新导致了设计和功能的改善，特别是在复杂和具有挑战性的胃肠道条件下，导致在特定应用中越来越受欢迎。 镍钛合金（主导）与聚氨酯（新兴） Nitinol 支架因其卓越的柔韧性和生物相容性而受到认可，使其在需要支架穿越曲线和复杂解剖通路的情况下成为理想选择。它们的形状记忆使其在变形后能够恢复到预定形状，这对于植入后维持功能至关重要。相比之下，聚氨酯支架因其生物相容性和灵活性而成为一种多功能替代品。它们在特定临床场景中越来越多地被使用，尤其是在需要低轮廓设备的情况下，研究人员正在探索其在长期应用中的潜力。这两种材料展示了市场上经过验证的方法与创新方法之间的平衡。 ### 按长度：10-20厘米（最大）与> 30厘米（生长最快） 在胃肠道支架市场中，‘长度’细分市场在各种支架长度之间显示出多样的市场份额分布，其中10-20厘米类别作为最大的细分市场占据了显著份额。紧随其后，20-30厘米的支架也展现出显著的存在，特别是满足特定治疗需求。相反，超过30厘米的支架正逐渐被认可，满足独特病例的需求，并在近年来扩大了其市场份额。长度细分市场的增长趋势受到多个因素的推动。医疗技术的进步提高了胃肠道支架的有效性和可用性，特别是对于较长的支架。此外，胃肠道疾病的发病率上升推动了对较长支架的需求，这些支架通常在复杂的临床案例中是必需的。这一不断发展的格局推动了对较长支架使用的趋势，尤其是在新兴市场，医疗设施正在升级其能力。 10-20 厘米（主导）与 > 30 厘米（新兴） 10-20厘米长度的支架因其多功能性和广泛适用性而成为胃肠道支架市场的主导力量，能够治疗多种胃肠道疾病。这些支架特别受到青睐，因为它们能够应对各种解剖挑战，适用于良性和恶性梗阻。另一方面，超过30厘米的支架代表了一个新兴细分市场，满足标准长度不足的更专业的案例。它们的增长受到复杂手术需求增加的推动，这些手术需要更长的支架，表明个性化治疗方法和医疗专业人员不断变化的需求正在发生转变。 ### 按直径：10-15毫米（最大）与> 20毫米（增长最快） 在胃肠道支架市场中，直径为‘10-15 mm’的细分市场占据了最大的市场份额，这表明由于其在治疗各种胃肠道疾病方面的多功能性，市场对这一尺寸的偏好广泛。医疗提供者青睐这一尺寸，因为它在有效性和插入的便利性之间取得了平衡。相比之下，‘> 20 mm’的细分市场正在迅速崛起，显示出由于支架技术的进步和患者对复杂病例中更大支架需求的增加，市场需求正在上升。 直径：10-15 毫米（主导）与 > 20 毫米（新兴） 直径为‘10-15 毫米’的支架在胃肠市场中占据主导地位，因其最佳设计满足多样化的临床需求。这些支架在治疗胃肠道的狭窄和阻塞等病症方面提供可靠的性能。相比之下，‘> 20 毫米’细分市场正在崛起，受到提升患者结果的创新驱动。这些较大的支架针对需要高级干预的特定患者群体，标志着向量身定制治疗方案的趋势。随着材料和设计的进步，预计对较大支架的需求将上升，突显了治疗方法的转变。 ## Regional Market Share Analysis ### 北美：创新的市场领导者 北美是胃肠支架最大的市场，约占全球市场份额的45%。该地区的增长受到先进医疗基础设施、胃肠疾病的日益普遍以及对创新医疗技术的强烈关注的推动。来自FDA等机构的监管支持进一步促进了市场扩展，确保支架部署的安全性和有效性。美国是主要贡献者，波士顿科学、美敦力和库克医疗等关键企业在竞争格局中处于领先地位。这些主要公司的存在促进了创新并增强了产品的可用性。加拿大也发挥了重要作用，随着对微创手术需求的增长，进一步巩固了北美作为胃肠支架进步中心的地位。 ### 欧洲：具有增长潜力的新兴市场 欧洲是胃肠支架第二大市场，约占全球市场份额的30%。该地区的增长受到老龄化人口、医疗支出增加和对胃肠疾病认识提高的推动。医疗器械法规（MDR）等监管框架确保了产品安全性和有效性的高标准，增强了消费者信心和市场增长。该地区的主要国家包括德国、法国和英国，这里观察到对医疗技术的重大投资。B. Braun Melsungen AG和奥林巴斯公司等关键企业积极参与产品开发和创新。竞争格局的特点是成熟公司与新兴初创企业的结合，增强了整体市场动态。 ### 亚太地区：快速增长的市场细分 亚太地区的胃肠支架市场正在迅速增长，约占全球市场份额的20%。该地区的扩展受到医疗可及性提高、可支配收入增加和胃肠疾病日益普遍的推动。中国和印度等国对先进医疗技术的需求显著，政府倡议支持改善医疗基础设施。中国是该地区最大的市场，医疗行业蓬勃发展，医疗设备投资不断增加。竞争格局中既有本地企业也有国际企业，包括Terumo Corporation和奥林巴斯公司。这些公司的存在增强了产品的可用性和创新，满足了亚太地区人口的多样化需求。 ### 中东和非洲：具有潜力的未开发市场 中东和非洲地区是胃肠支架的新兴市场，约占全球市场份额的5%。增长受到医疗投资增加、对胃肠疾病认识提高和人口增长的推动。该地区的政府正专注于改善医疗基础设施，这预计将推动对包括支架在内的先进医疗设备的需求。南非和阿联酋等国在市场中处于领先地位，对医疗技术和医学研究进行了重大投资。竞争格局正在演变，本地和国际企业都在寻求建立立足点。库克医疗和波士顿科学等关键企业的存在正在增强市场动态，为该地区未来的增长铺平道路。 ## Competitive Benchmarking 胃肠支架市场的特点是动态的竞争格局，受到对微创手术需求增加和支架技术进步的推动。波士顿科学（美国）、美敦力（美国）和库克医疗（美国）等主要参与者处于市场前沿，各自采取不同的策略来增强市场存在感。波士顿科学（美国）专注于创新，特别是在开发生物可降解支架方面，这与日益增长的可持续医疗解决方案趋势相一致。与此同时，美敦力（美国）强调战略合作，与医疗服务提供者合作以改善患者结果并扩大其产品供应。库克医疗（美国）积极追求区域扩张，特别是在新兴市场，以利用胃肠疾病日益普遍的趋势。 市场结构似乎适度分散，多个参与者争夺市场份额。关键商业策略包括本地化制造以降低成本和优化供应链，这在维持竞争定价方面至关重要。这些主要公司的集体影响力塑造了市场动态，因为它们不断适应不断变化的医疗需求和监管环境。 2025年8月，波士顿科学（美国）宣布推出其新型生物可降解支架，旨在为食管狭窄患者提供服务。这一创新产品预计将显著提高患者舒适度，并减少重复手术的需求，从而使公司在可持续胃肠解决方案方面处于领先地位。这一发布的战略重要性在于其潜力可以解决未满足的临床需求，同时与更广泛的环保医疗设备趋势相一致。 2025年9月，美敦力（美国）与一家领先的远程医疗提供商达成合作，旨在将远程监测能力整合到其胃肠支架产品中。这一举措可能会增强患者参与度和对治疗方案的遵循，反映出向数字健康解决方案的日益增长的趋势。通过利用技术，美敦力旨在改善患者结果并简化胃肠疾病的管理。 2025年7月，库克医疗（美国）在亚洲扩大了其制造能力，旨在满足该地区对胃肠支架日益增长的需求。这一战略扩张不仅提高了供应链效率，还使库克医疗能够更好地服务于快速增长的市场。这一举措的重要性在于其潜力可以增强公司在医疗需求快速变化的地区的竞争优势。 截至2025年10月，胃肠支架市场的当前竞争趋势包括向数字化、可持续性和人工智能在产品开发中的整合的明显转变。战略联盟日益塑造市场格局，使公司能够汇聚资源和专业知识以推动创新。展望未来，竞争差异化可能会从传统的基于价格的竞争转向关注技术进步、创新解决方案和可靠的供应链，反映出医疗服务提供者和患者的优先事项的变化。 ## Recent News & Developments - **2024年第二季度：波士顿科学公司宣布获得美国FDA对AXIOS™支架和电切增强输送系统的批准，用于内镜引流胆囊** 波士顿科学公司获得FDA批准，允许其AXIOS™支架和电切增强输送系统在高风险外科患者中用于内镜引流胆囊。 - **2024年第一季度：奥林巴斯在欧洲推出HANAROSTENT®食道TTS** 奥林巴斯宣布在欧洲推出HANAROSTENT®食道TTS，这是一种新型的经内镜自扩展金属支架，旨在治疗食道狭窄。 - **2024年第二季度：库克医疗获得Evolution®胆道控制释放支架的CE标志** 库克医疗获得CE标志批准，允许其Evolution®胆道控制释放支架在欧盟的商业分销扩展。 - **2024年第二季度：美敦力宣布与直觉外科公司合作推进内腔支架解决方案** 美敦力与直觉外科公司达成战略合作，共同开发下一代内腔支架解决方案，用于胃肠道手术。 - **2024年第一季度：太永医疗获得美国FDA 510(k)批准，推出Niti-S™十二指肠支架** 太永医疗获得美国FDA的510(k)批准，允许其Niti-S™十二指肠支架在美国商业推出。 - **2024年第三季度：波士顿科学完成对GI Supply的收购** 波士顿科学完成对GI Supply的收购，该公司专注于内镜设备，包括胃肠道支架，以扩展其介入产品组合。 - **2024年第二季度：迈克罗科技内镜在美国推出新胆道支架系统** 迈克罗科技内镜宣布在美国推出其新胆道支架系统，旨在改善胆道阻塞病例的放置便利性和患者结果。 - **2025年第一季度：奥林巴斯在越南开设新的胃肠道支架制造设施** 奥林巴斯在越南开设了一家新的制造设施，专注于胃肠道支架的生产，旨在增加全球供应能力。 - **2025年第二季度：波士顿科学获得FDA批准，推出下一代WallFlex™结肠支架** 波士顿科学获得FDA批准，推出其下一代WallFlex™结肠支架，旨在管理恶性结肠梗阻。 - **2024年第一季度：美敦力任命新的胃肠业务部门总裁** 美敦力宣布任命一位新总裁，负责其胃肠业务部门，反映出其在扩展GI支架产品组合方面的战略重点。 - **2024年第三季度：太永医疗与嘉德健康签署美国胃肠支架市场的分销协议** 太永医疗与嘉德健康签署分销协议，以扩大其胃肠支架产品在美国的覆盖范围。 - **2025年第二季度：库克医疗在欧洲推出新型可生物降解食道支架** 库克医疗在欧洲推出新型可生物降解食道支架，为良性食道狭窄提供了传统金属支架的替代方案。 ## Report Scope | 2024年市场规模 | 3.653（十亿美元） | | --- | --- | | 2025年市场规模 | 3.842（十亿美元） | | 2035年市场规模 | 6.361（十亿美元） | | 年复合增长率（CAGR） | 5.17%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 关键公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 关键市场机会 | 生物可降解材料的进步提高了胃肠支架市场的患者结果。 | | 关键市场动态 | 技术进步和监管变化推动胃肠支架市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，胃肠支架市场的预计市场估值是多少？** A: 预计到2035年，胃肠支架市场的市场估值将达到63.61亿美元。 **Q: 2024年胃肠支架市场的市场估值是多少？** A: 2024年，胃肠道支架市场的整体市场估值为36.53亿美元。 **Q: 在2025年至2035年的预测期内，胃肠支架市场的预期CAGR是多少？** A: 在2025年至2035年的预测期内，胃肠支架市场的预期CAGR为5.17%。 **Q: 在胃肠道支架市场中，哪些公司被视为关键参与者？** A: 胃肠道支架市场的主要参与者包括波士顿科学公司、美敦力、库克医疗和B. Braun Melsungen AG。 **Q: 2025年金属支架的预计估值是多少？** A: 预计到2025年，金属支架的估值将介于15亿至25亿美元之间。 **Q: 2025年，胃支架的估值与十二指肠支架相比如何？** A: 到2025年，胃支架的预计价值将在12亿到20亿美元之间，而十二指肠支架的预计价值将在8亿到13亿美元之间。 **Q: 到2035年，自扩展支架的市场预期表现如何？** A: 自扩张支架预计到2035年将达到11亿至18亿美元的估值。 **Q: 在胃肠支架的生产中主要使用哪些材料？** A: 胃肠支架中主要使用的材料包括镍钛合金、不锈钢、聚氨酯和硅胶。 **Q: 2025年，超过30厘米的支架预期估值范围是多少？** A: 预计到2025年，超过30厘米的支架的估值范围约为19.53亿至28.21亿美元。 **Q: 支架的直径如何影响其市场估值？** A: 预计到2025年，直径为10-15毫米的支架的市场价值将在12亿至20亿美元之间，显示出显著的市场存在。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gastrointestinal-stent-market-29514*